Deep vein thrombosis and pulmonary embolism, collectively referred to as venous
thromboembolism, constitute a major global burden of disease. The diagnostic work-up of …

Purpose The findings from the observational studies comparing the effectiveness and safety
of non–vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists …

Background Factor Xa inhibitors and vitamin K antagonists (VKAs) are now recommended in
treatment guidelines for preventing stroke and systemic embolic events in people with atrial …

There are limited data on the frequency of hematoma expansion with DOACs. In a
prospective study that enrolled 61 DOAC-treated patients presenting with ICH within 24 …

摘要背景糖尿病合并心房颤动(atrial fibrillation, AF) 可能会导致血栓栓塞症的风险增加. 对于AF
患者, 如果抗栓治疗无效或者有禁忌, 另外还有一种治疗方法就是封堵左心耳(Left atrial …

Purpose The aim of this study was to estimate the prevalence of mortality among patients
due to adverse drug reactions that lead to hospitalisation (fatal ADR Ad), to explore the …

Background: Elderly population is known to be associated with polymedication,
comorbidities and altered drug pharmacokinetics. However, the most adequate oral …

Background The goal of this study was to compare the safety and effectiveness of individual
antiembolic interventions in nonvalvular atrial fibrillation (AF): novel oral anticoagulants …

Approximately half of patients started on an oral anticoagulant in the USA now receive one
of the newer direct oral anticoagulants (DOACs). Although there is an approved reversal …

Percutaneous coronary intervention (PCI) is considered a relatively safe procedure
associated with low rates of complications, but is inevitably associated with short and mid-to …